Novo Nordisk has had a major factory in Kalundborg, about an hour outside the Danish capital of Copenhagen, for 55 years. The ...
Novo Nordisk is leaving nothing to chance when ... The drugmaker said the investment at its main production site in Kalundborg, Denmark, will serve “the current and future product portfolio ...
Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.
Novo Nordisk, en stor läkemedelsproducent, har nyligen upplevt en aktiekollaps trots stor efterfrågan på sina produkter. Företaget tillverkar insulin och diabetesläkemedlet Ozempic, som har blivit ...